Reperfusion half-life: A novel pharmacodynamic measure of thrombolytic activity

José G. Merino, Lawrence L. Latour, Li An, Amie W. Hsia, Dong Wha Kang, Steven Warach

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE-We hypothesized that the probability of reperfusion can be modeled by an exponential decay (ie, half-life) function and that this reperfusion half-life is decreased by thrombolytic treatment. METHODS-Serial perfusion MRI scans were evaluated for evidence of reperfusion in intravenous tissue plasminogen activator-treated (n≤45) and untreated (n≤103) patients. The cumulative probability of reperfusion for each group was fit with exponential decay functions. The resulting reperfusion half-life (ie, the time it takes half the sample to reperfuse) was calculated. RESULTS-In untreated patients, a monoexponential decay function fit the data well (R≤0.95) with a half-life of 29.1 hours. In tissue plasminogen activator-treated patients, the data were best fit with a biexponential decay function (R≤0.99) that had a fast and a slow component. The fast component is attributable to tissue plasminogen activator therapy and has a half-life of 0.71 hours, whereas the slow component was similar to that of the untreated group. Approximately 3.5 hours after the start of treatment, the effect of tissue plasminogen activator on the probability of reperfusion was negligible. CONCLUSION-The probability of reperfusion can be well described by the reperfusion half-life. Determination of the fast component reperfusion half-life may be an approach to compare the relative potency of different thrombolytic agents.

Original languageEnglish (US)
Pages (from-to)2148-2150
Number of pages3
JournalStroke
Volume39
Issue number7
DOIs
StatePublished - Jul 1 2008

Fingerprint

Reperfusion
Half-Life
Tissue Plasminogen Activator
Fibrinolytic Agents
Therapeutics
Perfusion
Magnetic Resonance Imaging

Keywords

  • MRI
  • Reperfusion
  • Stroke
  • Thrombolytic therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Medicine(all)

Cite this

Merino, J. G., Latour, L. L., An, L., Hsia, A. W., Kang, D. W., & Warach, S. (2008). Reperfusion half-life: A novel pharmacodynamic measure of thrombolytic activity. Stroke, 39(7), 2148-2150. https://doi.org/10.1161/STROKEAHA.107.510818

Reperfusion half-life : A novel pharmacodynamic measure of thrombolytic activity. / Merino, José G.; Latour, Lawrence L.; An, Li; Hsia, Amie W.; Kang, Dong Wha; Warach, Steven.

In: Stroke, Vol. 39, No. 7, 01.07.2008, p. 2148-2150.

Research output: Contribution to journalArticle

Merino, JG, Latour, LL, An, L, Hsia, AW, Kang, DW & Warach, S 2008, 'Reperfusion half-life: A novel pharmacodynamic measure of thrombolytic activity', Stroke, vol. 39, no. 7, pp. 2148-2150. https://doi.org/10.1161/STROKEAHA.107.510818
Merino JG, Latour LL, An L, Hsia AW, Kang DW, Warach S. Reperfusion half-life: A novel pharmacodynamic measure of thrombolytic activity. Stroke. 2008 Jul 1;39(7):2148-2150. https://doi.org/10.1161/STROKEAHA.107.510818
Merino, José G. ; Latour, Lawrence L. ; An, Li ; Hsia, Amie W. ; Kang, Dong Wha ; Warach, Steven. / Reperfusion half-life : A novel pharmacodynamic measure of thrombolytic activity. In: Stroke. 2008 ; Vol. 39, No. 7. pp. 2148-2150.
@article{432d40b4f2c44388bd2da7a501b0bcdf,
title = "Reperfusion half-life: A novel pharmacodynamic measure of thrombolytic activity",
abstract = "BACKGROUND AND PURPOSE-We hypothesized that the probability of reperfusion can be modeled by an exponential decay (ie, half-life) function and that this reperfusion half-life is decreased by thrombolytic treatment. METHODS-Serial perfusion MRI scans were evaluated for evidence of reperfusion in intravenous tissue plasminogen activator-treated (n≤45) and untreated (n≤103) patients. The cumulative probability of reperfusion for each group was fit with exponential decay functions. The resulting reperfusion half-life (ie, the time it takes half the sample to reperfuse) was calculated. RESULTS-In untreated patients, a monoexponential decay function fit the data well (R≤0.95) with a half-life of 29.1 hours. In tissue plasminogen activator-treated patients, the data were best fit with a biexponential decay function (R≤0.99) that had a fast and a slow component. The fast component is attributable to tissue plasminogen activator therapy and has a half-life of 0.71 hours, whereas the slow component was similar to that of the untreated group. Approximately 3.5 hours after the start of treatment, the effect of tissue plasminogen activator on the probability of reperfusion was negligible. CONCLUSION-The probability of reperfusion can be well described by the reperfusion half-life. Determination of the fast component reperfusion half-life may be an approach to compare the relative potency of different thrombolytic agents.",
keywords = "MRI, Reperfusion, Stroke, Thrombolytic therapy",
author = "Merino, {Jos{\'e} G.} and Latour, {Lawrence L.} and Li An and Hsia, {Amie W.} and Kang, {Dong Wha} and Steven Warach",
year = "2008",
month = "7",
day = "1",
doi = "10.1161/STROKEAHA.107.510818",
language = "English (US)",
volume = "39",
pages = "2148--2150",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Reperfusion half-life

T2 - A novel pharmacodynamic measure of thrombolytic activity

AU - Merino, José G.

AU - Latour, Lawrence L.

AU - An, Li

AU - Hsia, Amie W.

AU - Kang, Dong Wha

AU - Warach, Steven

PY - 2008/7/1

Y1 - 2008/7/1

N2 - BACKGROUND AND PURPOSE-We hypothesized that the probability of reperfusion can be modeled by an exponential decay (ie, half-life) function and that this reperfusion half-life is decreased by thrombolytic treatment. METHODS-Serial perfusion MRI scans were evaluated for evidence of reperfusion in intravenous tissue plasminogen activator-treated (n≤45) and untreated (n≤103) patients. The cumulative probability of reperfusion for each group was fit with exponential decay functions. The resulting reperfusion half-life (ie, the time it takes half the sample to reperfuse) was calculated. RESULTS-In untreated patients, a monoexponential decay function fit the data well (R≤0.95) with a half-life of 29.1 hours. In tissue plasminogen activator-treated patients, the data were best fit with a biexponential decay function (R≤0.99) that had a fast and a slow component. The fast component is attributable to tissue plasminogen activator therapy and has a half-life of 0.71 hours, whereas the slow component was similar to that of the untreated group. Approximately 3.5 hours after the start of treatment, the effect of tissue plasminogen activator on the probability of reperfusion was negligible. CONCLUSION-The probability of reperfusion can be well described by the reperfusion half-life. Determination of the fast component reperfusion half-life may be an approach to compare the relative potency of different thrombolytic agents.

AB - BACKGROUND AND PURPOSE-We hypothesized that the probability of reperfusion can be modeled by an exponential decay (ie, half-life) function and that this reperfusion half-life is decreased by thrombolytic treatment. METHODS-Serial perfusion MRI scans were evaluated for evidence of reperfusion in intravenous tissue plasminogen activator-treated (n≤45) and untreated (n≤103) patients. The cumulative probability of reperfusion for each group was fit with exponential decay functions. The resulting reperfusion half-life (ie, the time it takes half the sample to reperfuse) was calculated. RESULTS-In untreated patients, a monoexponential decay function fit the data well (R≤0.95) with a half-life of 29.1 hours. In tissue plasminogen activator-treated patients, the data were best fit with a biexponential decay function (R≤0.99) that had a fast and a slow component. The fast component is attributable to tissue plasminogen activator therapy and has a half-life of 0.71 hours, whereas the slow component was similar to that of the untreated group. Approximately 3.5 hours after the start of treatment, the effect of tissue plasminogen activator on the probability of reperfusion was negligible. CONCLUSION-The probability of reperfusion can be well described by the reperfusion half-life. Determination of the fast component reperfusion half-life may be an approach to compare the relative potency of different thrombolytic agents.

KW - MRI

KW - Reperfusion

KW - Stroke

KW - Thrombolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=47649085122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47649085122&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.107.510818

DO - 10.1161/STROKEAHA.107.510818

M3 - Article

C2 - 18451344

AN - SCOPUS:47649085122

VL - 39

SP - 2148

EP - 2150

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 7

ER -